GlassScriptPhysician profile
Emanuela Berari
NPI 1114465218
$786.54
in general payments reported to CMS, 2019-2025
18 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $151 · 2023: $150 · 2024: $203 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $215.02 | 2023-2025 | Collagenase Santyl, Renasys Touch, Iodosorb Ointment 40g USA |
| Inari Medical, INC. | $86.91 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Convatec INC. | $67.50 | 2023-2025 | |
| Next Science LLC | $65.05 | 2023 | Blastx, Xperience, Surgx |
| Astrazeneca Pharmaceuticals LP | $54.93 | 2021 | |
| Bioventus LLC | $50.18 | 2022 | |
| Tactile Systems Technology INC | $37.55 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Solventum Corporation | $33.99 | 2025 | V.A.C. Granufoam, V.A.C. Veraflo |
| Glaxosmithkline, LLC. | $28.51 | 2021 | |
| Cardiovascular Systems INC. | $22.26 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.24 | 2022 | |
| Novo Nordisk INC | $17.32 | 2024 | Ozempic, Rybelsus |
| Advanced Respiratory, INC | $17.10 | 2021 | |
| Cashflow Solutions, LLC | $16.67 | 2022 | |
| Boston Scientific Corporation | $16.45 | 2024 | Varithena Administration Pack |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $16.09 | 2025 | Restrata Wound Matrix |
| Hydrofera LLC | $14.61 | 2022 | |
| Genentech USA, INC. | $5.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emanuela Berari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.